- Management of bone metastases in refractory prostate cancer--role of denosumabChanning J Paller
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD 21287, USA
Clin Interv Aging 7:363-72. 2012..The role of denosumab in prostate cancer will continue to evolve either as monotherapy or in combination with other bone-targeting strategies...
- Sipuleucel-T for the treatment of metastatic prostate cancer: promise and challengesChanning J Paller
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA
Hum Vaccin Immunother 8:509-19. 2012....
- Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancerChanning J Paller
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD 21231, USA
Drug Des Devel Ther 5:117-24. 2011....